The Euratom Research and Training programme has the following specific objectives:
This action should provide catalytic and leveraging support for a preparatory phase aiming at bringing the project to a level of maturity required to potentially enable construction work to start on the EU’s production capability. It should therefore cover all relevant outstanding issues in strategic planning, technical work, financial arrangements and financing mechanisms, project logistics and legal aspects.
The preparatory phase should aim at optimal coordination, cross-border operation and possible integration of national research actions of trans-European interest in the field. This might lead to the possible setting up or reinforcement of legal entities to achieve optimal cooperation and joint programming. The preparatory phase should aim to bring the initiatives emerging today in different fields to the level of managerial, legal and financial maturity required to implement them.
To reduce the risk of nuclear proliferation, EU Member States are strongly committed to the principle of minimisation of highly enriched uranium, with the objective of converting research reactors and radioisotope production targets to high-assay low-enriched (19.75%) uranium (HALEU).
The preparatory phase should include:
After 2 years, a successful preparatory phase should lead to the implementation of joint programmes based on public-public and public-private partnerships, with increased efficiency and consistency as well as better visibility and attractiveness at global level.
100%
EU Contribution per project: €1.00 million
Approximate number of proposals: 1
Project consortia should involve all the stakeholders necessary to move the project forward, take decisions and make financial commitments before joint programmes can start (e.g. national or regional ministries or governments, research councils, funding agencies). Operators of research facilities, research centres, universities, industry and regulatory authorities should be involved where appropriate.
Contact: RTD-EURATOM@ec.europa.eu
(Publish Date: 04/04/2023-for internal use only)